TrinityPoint Wealth LLC increased its position in UnitedHealth Group Inc (NYSE:UNH) by 5.0% during the 2nd quarter, Holdings Channel.com reports. The firm owned 5,220 shares of the healthcare conglomerate’s stock after purchasing an additional 247 shares during the period. TrinityPoint Wealth LLC’s holdings in UnitedHealth Group were worth $1,311,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of UNH. Canton Hathaway LLC purchased a new stake in shares of UnitedHealth Group in the first quarter worth $36,000. Truvestments Capital LLC purchased a new stake in shares of UnitedHealth Group in the first quarter worth $42,000. Coastal Capital Group Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter worth $45,000. Creative Financial Designs Inc. ADV grew its stake in shares of UnitedHealth Group by 89.6% in the first quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after acquiring an additional 95 shares during the last quarter. Finally, Capital Advisors Ltd. LLC grew its stake in shares of UnitedHealth Group by 235.7% in the second quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock worth $57,000 after acquiring an additional 165 shares during the last quarter. 85.37% of the stock is currently owned by institutional investors.
UNH stock traded down $6.03 during trading on Thursday, reaching $234.32. The stock had a trading volume of 2,476,878 shares, compared to its average volume of 3,151,811. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $287.94. The stock’s 50 day moving average is $251.29 and its two-hundred day moving average is $247.40. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62. The firm has a market cap of $231.91 billion, a PE ratio of 18.19, a PEG ratio of 1.30 and a beta of 0.61.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s dividend payout ratio is 33.54%.
In other news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the transaction, the director now owns 187,663 shares of the company’s stock, valued at $46,540,424. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the completion of the transaction, the director now directly owns 61,309 shares in the company, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. In the last three months, insiders sold 37,000 shares of company stock worth $9,195,620. 0.87% of the stock is owned by corporate insiders.
A number of equities research analysts have recently commented on the company. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price on the stock in a research note on Monday, July 22nd. Morgan Stanley increased their price objective on UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a research report on Friday, July 12th. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Royal Bank of Canada set a $311.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, Raymond James increased their price objective on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research report on Friday, July 19th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have given a buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $295.06.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Why do companies issue convertible shares?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.